Is it all about itch?

Article

Time and again, we hear the mantra about itch and allergy-if it itches, then it’s allergy. For most patients, this holds true. But, there are times when there are no itch symptoms, but allergy is present. Experience has taught one clinician that there are 5 symptoms that mean allergic conjunctivitis.

Time and time again, we hear the mantra about itch and allergy-if it itches, then it’s allergy. For most patients, this holds true. But, there are times when there are no itch symptoms, but allergy is present. It’s almost to the point where our obsession with itch can mislead rather than lead to the right diagnosis.

What I have learned the hard way is there are five symptoms I look for in allergic conjunctivitis:

  • Itch (of course)

  • Redness

  • Watery eyes

  • Swelling

  • Dryness

Redness and swelling are classic signs of inflammation. But, watery eyes and dryness? Yes, this seems contradictory in itself.

Figure 1. OCT image of tear meniscus height.

How did I come up with this nonsensical conclusion? I participated in a study on itch and tear meniscus heights.1 In our small study, we found a negative correlation between the severity of itch and meniscus heights measured with OCT (see Figure 1). In other words, the lower the tear meniscus height, the more severe the itch becomes. We know that low tear meniscus heights indicate poor tear volume (aqueous tear deficiency) or dryness. So, the drier the eye, the worse the itch gets.

Do we see itch when the eye is watery or when it is dry? Most likely, when it is dry. Why is this? When there is a lower tear volume, the concentration of inflammatory factors in the tears goes up and elicits the itch response. Basically, I see the itch and dryness linked together, and watery as another symptom that occurs at a different time point during the allergic response.2

Now I look beyond itch for allergic conjunctivitis. Dryness, watery eyes, redness, and swelling play equally important roles.ODT

Reference

1.   Hom MM. Nguyen AL. Bielory L. Tear meniscus height by optical coherence tomography (OCT) and ocular itch. Academy of Asthma Allergy and Immunology. 2013 Poster #410 Session # 3210

2.   Bielory L. Ocular symptom reduction in patients with seasonal allergic rhinitis treated with the intranasal corticosteroid mometasone furoate. Ann Allergy Asthma Immunol. 2008 Mar;100(3):272-279.

 

 

5 symptoms of allergic conjunctivitis

• Itch (of course)

• Redness

• Watery eyes

• Swelling

• Dryness

 

 

Recent Videos
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
© 2024 MJH Life Sciences

All rights reserved.